See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

STAT™ Medical Devices

Roger Huckleberry

STAT™ Medical Devices

Nuevas Pequeñas Molécula Drogas Para El Tipo 2  - Ensayos Humanos En Curso

Christoph Westphal, MD, Ph.D - CEO SIRTRIS (GSK)

Nuevas Pequeñas Molécula Drogas Para El Tipo 2  - Ensayos Humanos En Curso

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

Glucagon

Updated 6 days ago
The Link Between Diabetes and Hormones
Jan 20, 2015 | 
Diabetes begins as a metabolic syndrome that features a combination of hormonal and nutritional imbalances. If these imbalances aren’t corrected, a pre-diabetic condition can turn into full-fledged diabetes. These hormonal imbalances can result in an inability for your body to produce the insulin that it needs to convert glucose into energy, a condition that is known as insulin resistance. When this occurs, your blood glucose levels will elevate, and you may experience complications and symptoms of diabetes. Likewise, if you suffer from glucose intolerance you may experience low blood sugar when your body doesn’t have enough glucose to use for fuel. 
New Dual Artificial Pump- Still in Development
Sep 5, 2014 | 
Tandem is in partnership with the JDRF to develop a dual hormone pump which will continue to be funded, as Tandem reaches different milestones. Once approved by the FDA, this novel and groundbreaking medical device will have two hormone chambers. One chamber for insulin, the second chamber for a different hormone that supports different therapies. “At this time, insulin is the only approved hormone for an insulin pump,” says Susan Morrison, Chief Administrative Officer from Tandem Diabetes Care.
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

STAT™ Medical Devices

Roger Huckleberry

STAT™ Medical Devices

Nuevas Pequeñas Molécula Drogas Para El Tipo 2  - Ensayos Humanos En Curso

Christoph Westphal, MD, Ph.D - CEO SIRTRIS (GSK)

Nuevas Pequeñas Molécula Drogas Para El Tipo 2  - Ensayos Humanos En Curso

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

Glucagon Study Shows Promise for Type 1s
Sep 8, 2013 | 
In the healthcare field today, perhaps no area holds as much promise and as many perils as weight control. Researchers see the same statistics that the rest of us do. They see the upcoming wave of obesity and diabetes diagnoses. They see the myriad complications that spring up from these conditions. And they want to address the problem in a simple way.
"Bionic Pancreas" Project Sets 4-Year Goal
Aug 2, 2013 | 
Could a "bionic pancreas"-a combination of insulin pump, continuous glucose monitor and predictive software-be on the market within four years? That 2017 date is the ambitious goal of a project from researchers at Boston University and Massachusetts General Hospital.
Taiwanese Study Identifies Top Three Drugs for Type 2 Glycemic Control
May 16, 2012 | 
Researchers in Taipei, Taiwan, report that they have identified the top three drugs for reducing A1C levels in type 2 diabetes: biphasic insulin, GLP-1 analogs, and basal insulin. They hedged a little on their endorsement of GLP-1 analogs, however, by saying that although they are not decisively better at controlling A1Cs than other oral diabetes drugs, they have the advantage of helping to reduce weight without adding to the danger of hypoglycemia.
FDA OKs Sale of Combo Drug JANUMET® XR
Feb 6, 2012 | 
The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin and extended-release metformin. The drug is the fourth oral type 2 diabetes treatment introduced by Merck, which also sells JANUVIA, JANUMET, and JUVISYNC.
The Night I Needed a Glucagon Injection
Oct 29, 2011 | 
The one time I needed a glucagon injection, I didn't have any. I had never been given a prescription for it, had no idea how to use it, and was absolutely clueless about what it did.
Next Page »  
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.